View ValuationThis company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsHPX 将来の成長Future 基準チェック /06主要情報n/a収益成長率n/aEPS成長率Capital Markets 収益成長11.6%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 170%After last week's 170% share price gain to US$27.07, the stock trades at a trailing P/E ratio of 67.6x. Average trailing P/E is 28x in the Capital Markets industry in the US. Total returns to shareholders of 173% over the past year.Board Change • Feb 14High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO, CFO & Director Carlos Leone Piani is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Nov 15HPX Corp. announced delayed 10-Q filingOn 11/14/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 093GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction.3GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction on July 5, 2022. The combined company is expected to have a pro-forma enterprise value of approximately $581 million and a pro-forma implied market capitalization of approximately $798 million, assuming no redemptions from HPX Corp. shareholders. Upon closing of the Business Combination, Ambipar Emergency Response (“Ambipar Response”), a newly incorporated Cayman Islands exempted company that will hold the business of Emergência Participações S.A., is expected to become publicly listed on the NYSE under the ticker symbol “AMBI.” Ambipar Participações e Empreendimentos S.A. (“Ambipar Group”) (B3: AMBP3), currently the sole shareholder of Emergência Participações S.A., will remain a majority shareholder of Ambipar Response with an approximate 50% equity stake in Ambipar Response following the closing of the Business Combination and assuming no redemptions from HPX’s existing public shareholders, and up to 72% in case of total redemptions of HPX existing public shareholders. The economic ownership structure following the Business Combination is expected to be approximately: 50% Ambipar Group, 48% PIPE and HPX public shareholders, and 2% HPX sponsor. The consummation of the transactions contemplated by the Business Combination Agreement is subject to customary closing conditions, including approval by shareholders of HPX and Ambipar; HPX having at least $5,000,001 of net tangible assets; the receipt of approval for the New PubCo Class A Ordinary Shares to be listed on NYSE; delivery of the Contribution Agreement; HPX shall have at least $168,000,000 in cash and cash equivalents in the Trust Account; Parties will have received or have been deemed to have received all other necessary pre-Closing authorizations, consents, clearances, waivers and approvals of the Governmental Entities; The Registration Statement shall have become effective in accordance with the provisions of the Securities Act and other conditions. The Business Combination has been unanimously approved by the Board of Directors of Ambipar Group and HPX. Ambipar Participações e Empreendimentos S.A., shareholder of Emergência Participações S.A. also approved the merger agreement. Transaction is expected to close during the second half of 2022. Bank of America Merrill Lynch Banco Múltiplo S.A. is serving as financial advisor to Ambipar Response and Ambipar Group, and BofA Securities, Inc. is serving as the placement agent in connection with the PIPE offering. Mark Pflug and Grenfel Calheiros, Mark Brod, Tristan Brown, Lori Lesser, Mick Tuesley of Simpson Thacher & Bartlett LLP serving as U.S. legal advisors to Ambipar Response and Ambipar Group, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados is serving as Brazilian legal advisor to Ambipar Response and Ambipar Group. J. Mathias von Bernuth and Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP serving as U.S. legal advisors to HPX, Greenberg Traurig, LLP is serving as legal advisor on certain international diligence matters for HPX and BRZ Advogados as legal advisor on Brazilian matters. Shearman & Sterling LLP is acting as legal advisor to BofA Securities, Inc. in its capacity as the placement agent.お知らせ • May 17HPX Corp. announced delayed 10-Q filingOn 05/16/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 01HPX Corp. announced delayed annual 10-K filingOn 03/31/2022, HPX Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • May 29HPX Corp. Receives Notice from the NYSE Regarding Delayed Filing of Quarterly ReportOn April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the U.S. Securities and Exchange Commission (the “SEC”) together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (‘SPACs’)” (the “SEC Staff Statement”). As previously disclosed, given the scope of the process for determining the appropriate accounting treatment of its outstanding warrants in accordance with the SEC Staff Statement and Accounting Standards Codification (“ASC”) 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, HPX Corp. (the “Company”) was unable to complete and file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the “Form 10-Q”) by the required due date without unreasonable effort and expense. On May 25, 2021, HPX Corp. received a notice (the “Notice”) from the New York Stock Exchange (the “Exchange”) indicating that, as a result of not having timely filed the Form 10-Q with the SEC, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires listed companies to timely file all required periodic reports with the SEC. The Notice indicated that the Company can regain compliance with the Exchange’s listing standards at any time prior to November 24, 2021 by filing the Form 10-Q. If the Company fails to file the Form 10-Q by such date, the Exchange may grant, at its sole discretion, an extension for the Company to regain compliance, depending on the specific circumstances. The Notice also stated that the Exchange may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant. While the Company can provide no assurances as to timing, the Company plans to file the Form 10-Q as soon as practicably possible, and no later than November 24, 2021, and regaining compliance with the Listing Rule.お知らせ • May 19HPX Corp. announced delayed 10-Q filingOn 05/18/2021, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Is New 90 Day High Low • Jan 26New 90-day high: US$10.61The company is up 10.0% from its price of US$9.65 on 27 October 2020. The American market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 24% over the same period.Is New 90 Day High Low • Jan 05New 90-day high: US$10.31The company is up 6.0% from its price of US$9.75 on 06 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 19% over the same period.Is New 90 Day High Low • Dec 14New 90-day high: US$9.98The company is up 1.0% from its price of US$9.85 on 14 September 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 16% over the same period.お知らせ • Dec 10Hpx Corp. Announces Board ChangesOn December 3, 2020, F bio Mour o informed HPX Corp. of his decision to resign from the board of directors of the company and as a member of the audit committee and chairman of the nominating and corporate governance committee, effective as of December 3, 2020. Mr. Mour o's resignation was voluntary and to pursue other professional endeavors and not the result of any disagreement with the operations, policies or practices of the company. Marcos Vinicius Bernardes Peigo, a director of the Company, was appointed to the audit committee in order to fill the seat left vacant by Mr. Mour o's departure. In addition, Mr. Peigo was appointed as the new chairman of the nominating and corporate governance committee. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、HPX は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測NYSEAM:HPX - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/2022N/A3-1-1N/A6/30/2022N/A12-1-1N/A3/31/2022N/A10-1-1N/A12/31/2021N/A9-1-1N/A9/30/2021N/A400N/A6/30/2021N/A-6-1-1N/A3/31/2021N/A-4-1-1N/Aアナリストによる今後の成長予測収入対貯蓄率: HPXの予測収益成長が 貯蓄率 ( 2.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: HPXの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: HPXの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: HPXの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: HPXの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: HPXの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YDiversified-financials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/03/07 17:32終値2023/03/06 00:00収益2022/09/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋HPX Corp. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 170%After last week's 170% share price gain to US$27.07, the stock trades at a trailing P/E ratio of 67.6x. Average trailing P/E is 28x in the Capital Markets industry in the US. Total returns to shareholders of 173% over the past year.
Board Change • Feb 14High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO, CFO & Director Carlos Leone Piani is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Nov 15HPX Corp. announced delayed 10-Q filingOn 11/14/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 093GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction.3GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction on July 5, 2022. The combined company is expected to have a pro-forma enterprise value of approximately $581 million and a pro-forma implied market capitalization of approximately $798 million, assuming no redemptions from HPX Corp. shareholders. Upon closing of the Business Combination, Ambipar Emergency Response (“Ambipar Response”), a newly incorporated Cayman Islands exempted company that will hold the business of Emergência Participações S.A., is expected to become publicly listed on the NYSE under the ticker symbol “AMBI.” Ambipar Participações e Empreendimentos S.A. (“Ambipar Group”) (B3: AMBP3), currently the sole shareholder of Emergência Participações S.A., will remain a majority shareholder of Ambipar Response with an approximate 50% equity stake in Ambipar Response following the closing of the Business Combination and assuming no redemptions from HPX’s existing public shareholders, and up to 72% in case of total redemptions of HPX existing public shareholders. The economic ownership structure following the Business Combination is expected to be approximately: 50% Ambipar Group, 48% PIPE and HPX public shareholders, and 2% HPX sponsor. The consummation of the transactions contemplated by the Business Combination Agreement is subject to customary closing conditions, including approval by shareholders of HPX and Ambipar; HPX having at least $5,000,001 of net tangible assets; the receipt of approval for the New PubCo Class A Ordinary Shares to be listed on NYSE; delivery of the Contribution Agreement; HPX shall have at least $168,000,000 in cash and cash equivalents in the Trust Account; Parties will have received or have been deemed to have received all other necessary pre-Closing authorizations, consents, clearances, waivers and approvals of the Governmental Entities; The Registration Statement shall have become effective in accordance with the provisions of the Securities Act and other conditions. The Business Combination has been unanimously approved by the Board of Directors of Ambipar Group and HPX. Ambipar Participações e Empreendimentos S.A., shareholder of Emergência Participações S.A. also approved the merger agreement. Transaction is expected to close during the second half of 2022. Bank of America Merrill Lynch Banco Múltiplo S.A. is serving as financial advisor to Ambipar Response and Ambipar Group, and BofA Securities, Inc. is serving as the placement agent in connection with the PIPE offering. Mark Pflug and Grenfel Calheiros, Mark Brod, Tristan Brown, Lori Lesser, Mick Tuesley of Simpson Thacher & Bartlett LLP serving as U.S. legal advisors to Ambipar Response and Ambipar Group, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados is serving as Brazilian legal advisor to Ambipar Response and Ambipar Group. J. Mathias von Bernuth and Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP serving as U.S. legal advisors to HPX, Greenberg Traurig, LLP is serving as legal advisor on certain international diligence matters for HPX and BRZ Advogados as legal advisor on Brazilian matters. Shearman & Sterling LLP is acting as legal advisor to BofA Securities, Inc. in its capacity as the placement agent.
お知らせ • May 17HPX Corp. announced delayed 10-Q filingOn 05/16/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 01HPX Corp. announced delayed annual 10-K filingOn 03/31/2022, HPX Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • May 29HPX Corp. Receives Notice from the NYSE Regarding Delayed Filing of Quarterly ReportOn April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the U.S. Securities and Exchange Commission (the “SEC”) together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (‘SPACs’)” (the “SEC Staff Statement”). As previously disclosed, given the scope of the process for determining the appropriate accounting treatment of its outstanding warrants in accordance with the SEC Staff Statement and Accounting Standards Codification (“ASC”) 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, HPX Corp. (the “Company”) was unable to complete and file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the “Form 10-Q”) by the required due date without unreasonable effort and expense. On May 25, 2021, HPX Corp. received a notice (the “Notice”) from the New York Stock Exchange (the “Exchange”) indicating that, as a result of not having timely filed the Form 10-Q with the SEC, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires listed companies to timely file all required periodic reports with the SEC. The Notice indicated that the Company can regain compliance with the Exchange’s listing standards at any time prior to November 24, 2021 by filing the Form 10-Q. If the Company fails to file the Form 10-Q by such date, the Exchange may grant, at its sole discretion, an extension for the Company to regain compliance, depending on the specific circumstances. The Notice also stated that the Exchange may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant. While the Company can provide no assurances as to timing, the Company plans to file the Form 10-Q as soon as practicably possible, and no later than November 24, 2021, and regaining compliance with the Listing Rule.
お知らせ • May 19HPX Corp. announced delayed 10-Q filingOn 05/18/2021, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Is New 90 Day High Low • Jan 26New 90-day high: US$10.61The company is up 10.0% from its price of US$9.65 on 27 October 2020. The American market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 24% over the same period.
Is New 90 Day High Low • Jan 05New 90-day high: US$10.31The company is up 6.0% from its price of US$9.75 on 06 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 19% over the same period.
Is New 90 Day High Low • Dec 14New 90-day high: US$9.98The company is up 1.0% from its price of US$9.85 on 14 September 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 16% over the same period.
お知らせ • Dec 10Hpx Corp. Announces Board ChangesOn December 3, 2020, F bio Mour o informed HPX Corp. of his decision to resign from the board of directors of the company and as a member of the audit committee and chairman of the nominating and corporate governance committee, effective as of December 3, 2020. Mr. Mour o's resignation was voluntary and to pursue other professional endeavors and not the result of any disagreement with the operations, policies or practices of the company. Marcos Vinicius Bernardes Peigo, a director of the Company, was appointed to the audit committee in order to fill the seat left vacant by Mr. Mour o's departure. In addition, Mr. Peigo was appointed as the new chairman of the nominating and corporate governance committee.